OverviewSuggest Edit

NeuroOne Medical Technologies is a medical technology company providing diagnostic and treatment devices for EEG recording, brain stimulation, and ablation. It is focused on the development and commercialization of thin-film electrode technology for electrocorticography (ECoG) and stereoelectroencephalography (sEEG) recording of brain activity. The company aims to help patients with epilepsy, Parkinson’s disease, essential tremors, and other related neurological disorders.

Latest Updates

Employees (est.) (Mar 2020)4
Share Price (Mar 2020)$2 (-1%)

NeuroOne Financials and Metrics

NeuroOne Revenue

Market capitalization (26-Mar-2020)


Closing stock price (26-Mar-2020)

NeuroOne's current market capitalization is $27.7 m.
Show all financial metrics

NeuroOne Online and Social Media Presence

Embed Graph

NeuroOne Frequently Asked Questions

  • When was NeuroOne founded?

    NeuroOne was founded in 2009.

  • How many employees does NeuroOne have?

    NeuroOne has 4 employees.

  • Who are NeuroOne competitors?

    Competitors of NeuroOne include IMRIS, CorFlow Therapeutics and Nyxoah.